[The efficacy of the long-term therapy of patients with stable stenocardia using korinfar and finoptin].

The authors evaluated the antianginal and hemodynamic effect of the combination of finoptin (80 mg) and corinfar (20 mg) in 52 patients with stable stenocardia. By the end of a three-month course of treatment the antianginal effect was marked in 49% of patients and this was related to reduced requirements of the myocardium in oxygen due to the peripheral hemodynamic effect of the agents and realization of the true coronary reserve under conditions of physical loading.